Literature DB >> 18682768

Perioperative chemotherapy: the case for adjuvant chemotherapy for muscle-invasive bladder cancer.

Alan So1.   

Abstract

Entities:  

Year:  2008        PMID： 18682768      PMCID： PMC2494889          DOI： 10.5489/cuaj.604

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  21 in total

1.  EORTC Group Study 30851: a phase II study of neoadjuvant chemotherapy in patients with invasive bladder cancer.

Authors:  T A Splinter; D Jacqmin; J T Roberts; M Pavone-Macaluso; M de Pauw; R Sylvester; P Carpentier
Journal:  Prog Clin Biol Res       Date:  1990

2.  Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

Authors:  Jan Lehmann; Ludger Franzaring; Joachim Thüroff; Stefan Wellek; Michael Stöckle
Journal:  BJU Int       Date:  2006-01       Impact factor: 5.588

3.  Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-25       Impact factor: 20.096

4.  Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.

Authors:  M Stöckle; W Meyenburg; S Wellek; G Voges; U Gertenbach; J W Thüroff; C Huber; R Hohenfellner
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

5.  Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I.

Authors:  E Rintala; E Hannisdahl; S D Fosså; S Hellsten; S Sander
Journal:  Scand J Urol Nephrol       Date:  1993

6.  Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.

Authors:  M Stöckle; W Meyenburg; S Wellek; G E Voges; M Rossmann; U Gertenbach; J W Thüroff; C Huber; R Hohenfellner
Journal:  J Urol       Date:  1995-01       Impact factor: 7.450

7.  Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial.

Authors:  U E Studer; M Bacchi; C Biedermann; P Jaeger; R Kraft; L Mazzucchelli; R Markwalder; E Senn; R W Sonntag
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

8.  A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.

Authors:  F Freiha; J Reese; F M Torti
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

9.  The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

Authors:  D G Skinner; J R Daniels; C A Russell; G Lieskovsky; S D Boyd; P Nichols; W Kern; J Sakamoto; M Krailo; S Groshen
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

10.  Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.

Authors:  P U Malmström; E Rintala; R Wahlqvist; P Hellström; S Hellsten; E Hannisdal
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.